TABLE 1.
Essential hypertension | Resistant hypertensiona | |
National Clinical Guideline Centre (United Kingdom 2011) [2] | Thiazide-like diuretics preferred over thiazide diuretics | Increase dose of thiazide-like diuretic treatment if K >4.5 mmol/l Use low-dose spironolactone if K ≤4.5 mmol/l |
National Heart Foundation of Australia (2016) [3] | Thiazides (chlorthalidone, HCTZ, or indapamide) | No instructions to change diuretic treatment Add spironolactone |
Hypertension Canada (2016) [4] | Thiazides, but longer acting thiazide-like diuretics preferred | No instructions to change diuretic treatment |
Latin American Society of Hypertension (2017) [5] | Thiazide diuretics, indapamide, and chlorthalidone equally recommended | No instructions to change diuretic treatment Use spironolactone and/or an alpha blocker |
American College of Cardiology/American Heart Association (2017) [6,7] | Thiazides, but chlorthalidone preferred | Maximize diuretic treatment (substitute HCTZ by indapamide or chlorthalidone) Add a mineralocorticoid receptor antagonist |
European Society of Cardiology and the European Society (2018) [8] | Thiazide/thiazide-like diuretics equally recommended | Add low-dose spironolactone Increase dose of thiazide if intolerance to spironolactone |
Terminology is defined as follows (not necessarily as defined in guidelines): thiazide, diuretics with a bicyclic benzothiadiazine backbone (such as HCTZ and bendroflumethiazide). Thiazide-like, diuretics that target the early segment of the distal convoluted tubule, but lack the bicyclic benzothiadiazine backbone (such as chlorthalidone, indapamide, and metolazone). Thiazide, thiazide and thiazide-like. HCTZ, hydrochlorothiazide; K, potassium.
aUncontrolled blood pressure despite the use of three antihypertensive agents of different classes including a diuretic.